1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Radiology AI Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porters Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Radiology AI Market, by Offering
8.1.1. On-Devices Software
8.1.1.1. Market Revenue and Forecast
8.1.2. Software/SaaS
8.1.2.1. Market Revenue and Forecast
9.1. Radiology AI Market, by Function
9.1.1. Screening & Triage
9.1.1.1. Market Revenue and Forecast
9.1.2. Diagnostic Imaging & Interpretation
9.1.2.1. Market Revenue and Forecast
9.1.3. Treatment Planning & Intervention Support
9.1.3.1. Market Revenue and Forecast
9.1.4. Monitoring & Follow-Up
9.1.4.1. Market Revenue and Forecast
9.1.5. Report & Documentation
9.1.5.1. Market Revenue and Forecast
9.1.6. Workflow Optimization
9.1.6.1. Market Revenue and Forecast
9.1.7. Research & Clinical Development
9.1.7.1. Market Revenue and Forecast
9.1.8. Research & Clinical Development
9.1.8.1. Market Revenue and Forecast
10.1. Radiology AI Market, by Modality
10.1.1. Computer Tomography (CT)
10.1.1.1. Market Revenue and Forecast
10.1.2. Magnetic Resonance Imaging (MRI)
10.1.2.1. Market Revenue and Forecast
10.1.3. X-Ray
10.1.3.1. Market Revenue and Forecast
10.1.4. Ultrasound
10.1.4.1. Market Revenue and Forecast
10.1.5. Mammography
10.1.5.1. Market Revenue and Forecast
11.1. Radiology AI Market, by Indication
11.1.1. Oncology
11.1.1.1. Market Revenue and Forecast
11.1.2. Cardiology
11.1.2.1. Market Revenue and Forecast
11.1.3. Neurology
11.1.3.1. Market Revenue and Forecast
11.1.4. Pulmonology/Respiratory Diseases
11.1.4.1. Market Revenue and Forecast
11.1.5. Orthopedics
11.1.5.1. Market Revenue and Forecast
12.1. Radiology AI Market, by End User
12.1.1. Hospitals
12.1.1.1. Market Revenue and Forecast
12.1.2. Diagnostic imaging centers
12.1.2.1. Market Revenue and Forecast
12.1.3. Others
12.1.3.1. Market Revenue and Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Offering
13.1.2. Market Revenue and Forecast, by Function
13.1.3. Market Revenue and Forecast, by Modality
13.1.4. Market Revenue and Forecast, by Indication
13.1.5. Market Revenue and Forecast, by End User
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Offering
13.1.6.2. Market Revenue and Forecast, by Function
13.1.6.3. Market Revenue and Forecast, by Modality
13.1.6.4. Market Revenue and Forecast, by Indication
13.1.6.5. Market Revenue and Forecast, by End User
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Offering
13.1.7.2. Market Revenue and Forecast, by Function
13.1.7.3. Market Revenue and Forecast, by Modality
13.1.7.4. Market Revenue and Forecast, by Indication
13.1.7.5. Market Revenue and Forecast, by End User
13.2. Europe
13.2.1. Market Revenue and Forecast, by Offering
13.2.2. Market Revenue and Forecast, by Function
13.2.3. Market Revenue and Forecast, by Modality
13.2.4. Market Revenue and Forecast, by Indication
13.2.5. Market Revenue and Forecast, by End User
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Offering
13.2.6.2. Market Revenue and Forecast, by Function
13.2.6.3. Market Revenue and Forecast, by Modality
13.2.7. Market Revenue and Forecast, by Indication
13.2.8. Market Revenue and Forecast, by End User
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Offering
13.2.9.2. Market Revenue and Forecast, by Function
13.2.9.3. Market Revenue and Forecast, by Modality
13.2.10. Market Revenue and Forecast, by Indication
13.2.11. Market Revenue and Forecast, by End User
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Offering
13.2.12.2. Market Revenue and Forecast, by Function
13.2.12.3. Market Revenue and Forecast, by Modality
13.2.12.4. Market Revenue and Forecast, by Indication
13.2.13. Market Revenue and Forecast, by End User
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Offering
13.2.14.2. Market Revenue and Forecast, by Function
13.2.14.3. Market Revenue and Forecast, by Modality
13.2.14.4. Market Revenue and Forecast, by Indication
13.2.15. Market Revenue and Forecast, by End User
13.3. APAC
13.3.1. Market Revenue and Forecast, by Offering
13.3.2. Market Revenue and Forecast, by Function
13.3.3. Market Revenue and Forecast, by Modality
13.3.4. Market Revenue and Forecast, by Indication
13.3.5. Market Revenue and Forecast, by End User
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Offering
13.3.6.2. Market Revenue and Forecast, by Function
13.3.6.3. Market Revenue and Forecast, by Modality
13.3.6.4. Market Revenue and Forecast, by Indication
13.3.7. Market Revenue and Forecast, by End User
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Offering
13.3.8.2. Market Revenue and Forecast, by Function
13.3.8.3. Market Revenue and Forecast, by Modality
13.3.8.4. Market Revenue and Forecast, by Indication
13.3.9. Market Revenue and Forecast, by End User
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Offering
13.3.10.2. Market Revenue and Forecast, by Function
13.3.10.3. Market Revenue and Forecast, by Modality
13.3.10.4. Market Revenue and Forecast, by Indication
13.3.10.5. Market Revenue and Forecast, by End User
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Offering
13.3.11.2. Market Revenue and Forecast, by Function
13.3.11.3. Market Revenue and Forecast, by Modality
13.3.11.4. Market Revenue and Forecast, by Indication
13.3.11.5. Market Revenue and Forecast, by End User
13.4. MEA
13.4.1. Market Revenue and Forecast, by Offering
13.4.2. Market Revenue and Forecast, by Function
13.4.3. Market Revenue and Forecast, by Modality
13.4.4. Market Revenue and Forecast, by Indication
13.4.5. Market Revenue and Forecast, by End User
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Offering
13.4.6.2. Market Revenue and Forecast, by Function
13.4.6.3. Market Revenue and Forecast, by Modality
13.4.6.4. Market Revenue and Forecast, by Indication
13.4.7. Market Revenue and Forecast, by End User
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Offering
13.4.8.2. Market Revenue and Forecast, by Function
13.4.8.3. Market Revenue and Forecast, by Modality
13.4.8.4. Market Revenue and Forecast, by Indication
13.4.9. Market Revenue and Forecast, by End User
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Offering
13.4.10.2. Market Revenue and Forecast, by Function
13.4.10.3. Market Revenue and Forecast, by Modality
13.4.10.4. Market Revenue and Forecast, by Indication
13.4.10.5. Market Revenue and Forecast, by End User
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Offering
13.4.11.2. Market Revenue and Forecast, by Function
13.4.11.3. Market Revenue and Forecast, by Modality
13.4.11.4. Market Revenue and Forecast, by Indication
13.4.11.5. Market Revenue and Forecast, by End User
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Offering
13.5.2. Market Revenue and Forecast, by Function
13.5.3. Market Revenue and Forecast, by Modality
13.5.4. Market Revenue and Forecast, by Indication
13.5.5. Market Revenue and Forecast, by End User
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Offering
13.5.6.2. Market Revenue and Forecast, by Function
13.5.6.3. Market Revenue and Forecast, by Modality
13.5.6.4. Market Revenue and Forecast, by Indication
13.5.7. Market Revenue and Forecast, by End User
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Offering
13.5.8.2. Market Revenue and Forecast, by Function
13.5.8.3. Market Revenue and Forecast, by Modality
13.5.8.4. Market Revenue and Forecast, by Indication
13.5.8.5. Market Revenue and Forecast, by End User
14.1. Siemens Healthineers AG
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Microsoft
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Koninklijke Philips
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. GE HealthCare
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Fujifilm Holdings Corporation
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Canon Medical Systems Corporation
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Lunit
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Lunit
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Shanghai United Imaging Healthcare
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Hologic
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
